Novare Capital Management LLC Has $272,000 Position in Kenvue Inc. $KVUE

Novare Capital Management LLC lowered its position in Kenvue Inc. (NYSE:KVUE) by 96.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 15,770 shares of the company’s stock after selling 466,025 shares during the quarter. Novare Capital Management LLC’s holdings in Kenvue were worth $272,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in KVUE. Allstate Corp acquired a new stake in Kenvue during the 3rd quarter valued at approximately $1,152,000. Aberdeen Group plc raised its holdings in Kenvue by 84.1% during the 3rd quarter. Aberdeen Group plc now owns 1,411,380 shares of the company’s stock worth $22,914,000 after purchasing an additional 644,930 shares during the last quarter. Oak Thistle LLC bought a new position in Kenvue during the 4th quarter worth approximately $1,563,000. Eubel Brady & Suttman Asset Management Inc. raised its holdings in Kenvue by 39.7% during the 3rd quarter. Eubel Brady & Suttman Asset Management Inc. now owns 1,371,886 shares of the company’s stock worth $22,266,000 after purchasing an additional 389,704 shares during the last quarter. Finally, Vest Financial LLC raised its holdings in Kenvue by 4.7% during the 3rd quarter. Vest Financial LLC now owns 2,436,986 shares of the company’s stock worth $39,552,000 after purchasing an additional 108,480 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

Several research analysts have issued reports on KVUE shares. Zacks Research upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Argus upgraded shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Canaccord Genuity Group raised their price target on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Finally, UBS Group lowered their price target on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, April 7th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat, Kenvue currently has an average rating of “Hold” and a consensus price target of $19.33.

Insider Activity at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.59% of the stock is currently owned by company insiders.

Kenvue Stock Performance

Shares of KVUE stock opened at $17.09 on Friday. The company has a market cap of $32.81 billion, a price-to-earnings ratio of 20.10, a price-to-earnings-growth ratio of 1.30 and a beta of 0.55. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $24.35. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. The firm has a 50 day moving average of $17.48 and a 200-day moving average of $17.32.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.27 by $0.05. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.24 EPS. On average, equities analysts forecast that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th will be given a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, May 13th. This represents a $0.83 annualized dividend and a dividend yield of 4.9%. Kenvue’s dividend payout ratio (DPR) is 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.